PHARMACELERA
Pharmacelera is a company that applies accurate Quantum-Mechanics (QM) algorithms, Machine Learning (ML) and High-Performance Computing (HPC) to mine an unexploited chemical space and propose molecular candidates that have higher chances to become a drug. The patented computational technology derives from more than 25 years of research at the University of Barcelona and it has been validated in scientific peer-reviewed publications and benchmarking studies performed by our users and customers.
PHARMACELERA
Industry:
Biotechnology Information Technology Life Science Machine Learning Pharmaceutical Software
Founded:
2015-01-19
Address:
Barcelona, Catalonia, Spain
Country:
Spain
Website Url:
http://www.new.pharmacelera.com
Total Employee:
11+
Status:
Active
Contact:
(+34) 654957229
Email Addresses:
[email protected]
Total Funding:
2.01 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome Global Site Tag
Similar Organizations
Aichoo
Machine Learning Operating System
Clyde Biosciences
Improving success in drug discovery
Hafnium Labs
B2B software for predicting chemistry.
Intellegens
Applied machine learning to accelerate innovation in materials, chemicals, manufacturing, and beyond.
Methinks
Deep learning in neuroimaging
Current Advisors List
Current Employees Featured
Founder
Newest Events participated
Participated in BHH Investors Day #1
on 2019-12-12 as exhibitor
Official Site Inspections
http://www.new.pharmacelera.com
- Host name: 217-160-0-236.elastic-ssl.ui-r.com
- IP address: 217.160.0.236
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Pharmacelera"
Pushing the limits of computational chemistry | Pharmacelera
Science is encoded in the DNA of Pharmacelera. Computational and medicinal chemistry, machine learning and artificial intelligence, quantum mechanics and high performance …See details»
Pharmacelera - Crunchbase Company Profile & Funding
Pharmacelera may be growing as it is mentioned alongside other companies in the context of the DNA-Encoded Library Market, which is projected to have a significant growth rate. The …See details»
Pharmacelera Company Profile 2024: Valuation, …
Pharmacelera General Information Description. Developer of a drug discovery platform designed to explore large and diverse chemical spaces. The …See details»
Pharmacelera - LinkedIn
Pharmacelera | 3,436 followers on LinkedIn. Mine enhanced chemical space. Design superior candidates | Quantum-Mechanics and Machine Learning Drug Discovery. Pharmacelera …See details»
An update from our CEO, Enric Gibert - LinkedIn
Dec 9, 2021 A single organization cannot revert the drug discovery R&D inefficiency by itself. It is a challenge that requires multiple views, complementary technologies and skills. Wishing …See details»
Pharmacelera - Scientist.com
Pharmacelera develops proprietary Computer-Aided Drug Design software and provides access to its technology through flexible licensing options and computational chemistry services. The …See details»
Pharmacelera, focused on disruptive solutions for Computer
Feb 4, 2021 Pharmacelera, a company that develops and applies accurate Quantum-Mechanics (QM) algorithms, Machine Learning (ML) models and High-Performance Computing (HPC) in …See details»
Pharmacelera - Products, Competitors, Financials, Employees ...
Pharmacelera is a company that specializes in the development of proprietary Computer-Aided Drug Design (CADD) software and offers computational chemistry services within the …See details»
Pharmacelera - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
Pushing the limits of computational chemistry - Pharmacelera
Jan 15, 2020 Pharmacelera: 2019 Summary. January 15, 2020 2019, collaborations, events, PharmScreen, projects, publications, summary, collaborations, events, PharmScreen, projects ...See details»
Pharmacelera - VDMHealth
Pharmacelera is a dynamic and innovative company that provides solutions and services for Computer-Aided Drug Design (CADD) and highperformance hardware and software solutions …See details»
PharmScreen - 3D ligand-based virtual screening software
Our field-based virtual screening software uses a unique and superior 3D representation of molecules based on electrostatic, steric and hydrophobic interaction fields derived from semi …See details»
Pharmacelera - Company info. interviews, news
Pharmacelera's solutions find candidate molecules that have higher chances to become a drug faster than the tools from the competition. The mission of the company is to improve the …See details»
Pharmacelera to partner with Enamine for the screening of ultra …
Dec 15, 2022 In this context, Pharmacelera and Enamine have reached an agreement to plug the Enamine Real Database - over 5.5 billion highly feasible compounds - into the new version …See details»
Machine Learning partnership to accelerate discovery of novel drugs
Jun 27, 2019 CCDC and Pharmacelera combine virtual screening and machine learning expertise to help scientists accelerate drug discovery. Barcelona and Cambridge, UK, 26 th …See details»
Events - Pharmacelera
Apr 1, 2022 Find out the latest and upcoming Pharmacelera's events, webinars, ... Stay tuned and let's meet physically or virtually.See details»
Pharmacelera extends the current partnership with Enamine for …
May 7, 2024 Barcelona, Spain, and Kyiv, Ukraine, 7 May 2024. Pharmacelera, the leading provider of computational tools for hit discovery, and Enamine, the developer of the world’s …See details»
Collaboration with Pharmacelera on AI for DEL screening
Apr 4, 2022 Pharmacelera is a private company founded in 2015 and based in Barcelona, Spain. The company works with several big pharma and biotech organizations across Europe and the …See details»
Pharmacelera - EU-Startups
Pharmacelera develops proprietary Computer-Aided Drug Design software and provides access to its technology through flexible licensing options and computational chemistry services. The …See details»
Mid 2021 Summary - Pharmacelera News
Jul 20, 2021 New release of PharmQSAR tool with new functionalities like the generation of predictive models and preparation of molecular libraries in a single tool. Iktos will apply …See details»